Methylenetetrahydrofolate reductase polymorphism in Kawasaki disease

Citation
H. Tsukahara et al., Methylenetetrahydrofolate reductase polymorphism in Kawasaki disease, PEDIATR INT, 42(3), 2000, pp. 236-240
Citations number
17
Categorie Soggetti
Pediatrics
Journal title
PEDIATRICS INTERNATIONAL
ISSN journal
13288067 → ACNP
Volume
42
Issue
3
Year of publication
2000
Pages
236 - 240
Database
ISI
SICI code
1328-8067(200006)42:3<236:MRPIKD>2.0.ZU;2-I
Abstract
Background: A genetic aberration in the 5,10-methylenetetrahydrofolate redu ctase (MTHFR) gene (677 C to T substitution) has been shown to result in re duced enzyme activity. The hypothesis tested in the present study was that a higher proportion of Kawasaki disease (KD) patients with coronary artery lesions (CAL) would have the T677 allele compared with patients without CAL and healthy subjects. Methods: Genotypes for MTHFR were determined in 75 KD patients (male : fema le ratio 52:23) and 238 healthy subjects (male : female ratio, 110:128) by the polymerase chain reaction and restriction fragment length polymorphism method. Results: The results indicated that female KD patients had a significantly higher frequency of the TT genotype compared with female control subjects. In the female population, the frequency of the TT genotype in patients with initial coronary aneurysm was significantly lower than in patients without this manifestation. Analysis of the data for the male population showed th at the frequency of the TT genotype in KD patients developing coronary sten osis, occlusion or myocardial infarction was higher than that in those with out these manifestations, although the difference was statistically insigni ficant. Conclusions: The TT genotype may protect female KD patients against initial aneurysm formation and predispose male KD patients to severe coronary comp lications. Further large-scale studies may be required to confirm the contr ibution of homocysteine in the coronary sequelae of KD.